Pharmaceuticals, Biotechnology and Life Sciences
36-Month Results of Phase 3 Trial in Chronic Low Back Pain Presented at 2022 Biotech ShowcaseNEW YORK, Jan. 11, 2022…
VANCOUVER, Washington, Jan. 11, 2022 (GLOBE NEWSWIRE) — CytoDyn Inc. (OTCQB: CYDY) (“CytoDyn” or the “Company”), a late-stage biotechnology company…
LAWRENCEVILLE, N.J., Jan. 10, 2022 (GLOBE NEWSWIRE) — Celsion Corporation (NASDAQ: CLSN), a clinical-stage development company focused on DNA-based immunotherapy…
Delivering platform expertise and developing novel microbes, molecules and materials for customers across a variety of marketsSAN FRANCISCO, Jan. 10,…
Announces inducement grant under NASDAQ Listing Rule 5635(c)(4)WAYNE, Pa. and ROCKVILLE, Md., Jan. 10, 2022 (GLOBE NEWSWIRE) — Avalo Therapeutics,…
Infant Bacterial Therapeutics AB (IBT) today announces that the Australian Patent Office has granted a patent entitled: A method of…
Agreement combines IASO Bio and Innovent’s CAR construct, validated in clinical trials, with Sana’s in vivo and ex vivo engineered…
• Allogene reported that Chromosomal Abnormality Was Not the Result of TALEN® Gene Editing or Allogene’s Manufacturing Process • Allogene…
Company has already booked multiple orders and established COEs in three major geographies Seer’s Proteograph Product Suite Announcing Broad Commercial…
“COVID Testing: What Needs to Happen Now to Turn the Corner in 2022” CEO blog released New York, NY, and…